|  Help  |  About  |  Contact Us

Publication : Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells.

First Author  Thijssen R Year  2020
Journal  Cell Death Differ Volume  27
Issue  8 Pages  2531-2533
PubMed ID  32555451 Mgi Jnum  J:306574
Mgi Id  MGI:6716806 Doi  10.1038/s41418-020-0576-2
Citation  Thijssen R, et al. (2020) Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells. Cell Death Differ 27(8):2531-2533
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

1 Bio Entities

Trail: Publication

0 Expression